New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
MyMD Pharmaceuticals, Inc.
MYMD
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

4M

Biotechnology

Next Earning date - 12 Nov 2024

4M

Biotechnology

Next Earning date - 12 Nov 2024

1.81USD
Shape-0.01 ( -0.55%)
favorite-chart

Relative Strenght

4
favorite-chart

Volume Buzz

-63%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

97%

Quote Panel

Shape
Updated October 12, 2024
1W % 1M % 3M 2.21 % 1Y -85.40 %

Key Metrics

Shape
  • Market Cap

    4.29M


  • Shares Outstanding

    2.37M


  • Share in Float

    2.11M


  • Dividende

    0


  • Earning Date

    12 Nov 2024


  • Price Target

    1.81


  • Average Volume

    61809


  • Beta

    2.692


  • Range

    1.75-63.9


  • Industry

    Biotechnology


  • Website

    https://www.mymd.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

0.00x

P/S Ratio

0.38x

P/B Ratio

0.0

Debt/Equity

0.0%

Net Margin

$-9.3

EPS

How MYMD compares to sector?

P/E Ratio

Relative Strength

Shape

MYMD

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

No Data Available

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q2.22

arrow
arrow

N/A

-2.70
vs -15.02

Q3.22

arrow
arrow

N/A

-2.70
vs -4.50

Q4.22

arrow
arrow

N/A

-2.70
vs -2.10

Q1.23

arrow
arrow

N/A

-1.20
vs -3.30

Q2.23

arrow
arrow

N/A

-4.50
vs -2.70

Q3.23

arrow
arrow

N/A

-3.30
vs -2.70

Q4.23

arrow
arrow

N/A

-2.70
vs -2.70

Q1.24

arrow
arrow

N/A

-5.14
vs -1.20

Q3.24

arrow
arrow

+141%

1.34
vs -3.30

Q4.24

arrow
arrow

+157%

1.54
vs -2.70

Sales GrowthShape

status-upYoY

Current

Estimates

Q4.21

arrow
arrow

NA

NA  vs NA

Q1.22

arrow
arrow

NA

NA  vs NA

Q2.22

arrow
arrow

NA

NA  vs NA

Q3.22

arrow
arrow

NA

NA  vs NA

Q4.22

arrow
arrow

NA

NA  vs NA

Q1.23

arrow
arrow

NA

NA  vs NA

Q2.23

arrow
arrow

NA

NA  vs NA

Q3.23

arrow
arrow

NA

NA  vs NA

Q4.23

arrow
arrow

NA

NA  vs NA

Q1.24

arrow
arrow

NA

NA  vs NA

Return on EquityShape

status-upQoQ

Q2.22

arrow
arrow

-23%

-0.23
vs -0.21

Q3.22

arrow
arrow

-20%

-0.20
vs -0.23

Q4.22

arrow
arrow

-25%

-0.25
vs -0.20

Q1.23

arrow
arrow

-3%

-0.03
vs -0.25

Q2.23

arrow
arrow

-39%

-0.39
vs -0.03

Q3.23

arrow
arrow

+25%

0.25
vs -0.39

Q4.23

arrow
arrow

-19%

-0.19
vs 0.25

Q1.24

arrow
arrow

-96%

-0.96
vs -0.19

Institutionnal OwnershipShape

status-upQoQ

Q3.19

arrow
arrow

1

1
vs NA

NA

Q4.19

arrow
arrow

7

7
vs 1

600%

Q1.20

arrow
arrow

11

11
vs 7

57%

Q2.20

arrow
arrow

8

8
vs 11

-27%

Q3.20

arrow
arrow

14

14
vs 8

75%

Q4.20

arrow
arrow

15

15
vs 14

7%

Q1.21

arrow
arrow

18

18
vs 15

20%

Q1.22

arrow
arrow

2

2
vs NA

NA

Earnings Growth

Latest News